Triage assessment of cardiorespiratory risk status based on measurement of the anaerobic threshold, and estimation by activity limitation in patients with pulmonary arteriovenous malformations and hereditary haemorrhagic telangiectasia
Saranya Thurairatnam, Filip Gawecki, Timothy Strangeways, Joseph Perks, Vatshalan Santhirapala, Jonathan Myers, Hannah C Tighe, Luke SGE Howard, View ORCID ProfileClaire L. Shovlin
doi: https://doi.org/10.1101/2020.03.27.20045203
Saranya Thurairatnam
1School of Medicine, Imperial College London UK
2Hull/York School of Medicine, UK
Filip Gawecki
1School of Medicine, Imperial College London UK
Timothy Strangeways
1School of Medicine, Imperial College London UK
Joseph Perks
5Respiratory Medicine, Imperial College Healthcare NHS Trust, London UK
BScVatshalan Santhirapala
6Imaging, Imperial College Healthcare NHS Trust, London UK
MB ChBJonathan Myers
7Respiratory Medicine, Imperial College Healthcare NHS Trust, London U
Hannah C Tighe
8Respiratory Medicine, Imperial College Healthcare NHS Trust, London UK
BScLuke SGE Howard
9National Pulmonary Hypertension Service, Imperial College Healthcare NHS Trust, London UK
DPhil FRCPClaire L. Shovlin
10NHLI Cardiovascular Sciences Imperial College London, UK; VASCERN HHT European Reference Centre and Respiratory Medicine, Imperial College Healthcare NHS Trust, London UK
PhD FRCPArticle usage
Posted April 20, 2020.
Triage assessment of cardiorespiratory risk status based on measurement of the anaerobic threshold, and estimation by activity limitation in patients with pulmonary arteriovenous malformations and hereditary haemorrhagic telangiectasia
Saranya Thurairatnam, Filip Gawecki, Timothy Strangeways, Joseph Perks, Vatshalan Santhirapala, Jonathan Myers, Hannah C Tighe, Luke SGE Howard, Claire L. Shovlin
medRxiv 2020.03.27.20045203; doi: https://doi.org/10.1101/2020.03.27.20045203
Triage assessment of cardiorespiratory risk status based on measurement of the anaerobic threshold, and estimation by activity limitation in patients with pulmonary arteriovenous malformations and hereditary haemorrhagic telangiectasia
Saranya Thurairatnam, Filip Gawecki, Timothy Strangeways, Joseph Perks, Vatshalan Santhirapala, Jonathan Myers, Hannah C Tighe, Luke SGE Howard, Claire L. Shovlin
medRxiv 2020.03.27.20045203; doi: https://doi.org/10.1101/2020.03.27.20045203
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)